SCHEMBL7094701

SCHEMBL7094701

Oc1ccc(-c2nn(Cc3ccccc3)c3ccsc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.53
ADORA3 P0DMS8 1/20 0.42
ADORA1 P30542 1/20 0.42
F2RL3 Q96RI0 1/20 0.41
ADORA2A P29274 1/20 0.41
ALDH1A1 P00352 4/20 0.41
FEN1 P39748 2/20 0.41
ERCC5 P28715 2/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HTR7 P34969 2/20 0.39
HTR1A P08908 1/20 0.39
HTR2A P28223 1/20 0.39
KDM4E B2RXH2 2/20 0.38
HPGD P15428 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094721 0.90 ADORA1 (0.50) ESR1ADORA3ADORA1F2RL3ADORA2A
SCHEMBL7096390 0.87 BTK (0.42) ESR1ADORA3ADORA1F2RL3ALDH1A1
SCHEMBL7090320 0.87 ALDH1A1 (0.54) ESR1ADORA3ADORA1F2RL3ALDH1A1
SCHEMBL7091163 0.84 F2RL3 (0.47) ESR1ADORA3ADORA1F2RL3ALDH1A1
SCHEMBL6994778 0.84 ADORA1 (0.45) ESR1ADORA3ADORA1F2RL3ADORA2A
SCHEMBL7093526 0.78 KMT2A (0.50) ADORA1ADORA2AALDH1A1KMT2AMEN1
SCHEMBL4028940 0.78 ESR1 (0.69) ESR1F2RL3ALDH1A1KMT2ACYP1A2
SCHEMBL7500320 0.74 PDE5A (0.46) ALDH1A1FEN1ERCC5KMT2AMEN1
SCHEMBL2953485 0.74 PDE5A (0.67) ALDH1A1FEN1ERCC5KMT2ACYP1A2
SCHEMBL13618712 0.73 PDE5A (0.66) ADORA3ADORA1ADORA2AALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed